11 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Rational Design of a Boron-Modified Triphenylethylene (GLL398) as an Oral Selective Estrogen Receptor Downregulator.
Xavier University of Louisiana
Identification of quinones as novel PIM1 kinase inhibitors.
Xavier University of Louisiana
A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2.
Xavier University of Louisiana
Some non-conventional biomolecular targets for diamidines. A short survey.
Xavier University of Louisiana
Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1.
Xavier University of Louisiana
Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells.
Xavier University of Louisiana
Factor XIIIa inhibitors as potential novel drugs for venous thromboembolism.
Xavier University of Louisiana
Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD).
Xavier University of Louisiana
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer.
Xavier University of Louisiana
Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid Tumors.
Xavier University of Louisiana
Chemical modulators of store-operated calcium channels and their therapeutic applications
The Texas A&M University System